Home/Response Pharmaceuticals/Craig M. Audet, Ph.D.
CM

Craig M. Audet, Ph.D.

Chief Regulatory Officer

Response Pharmaceuticals

Response Pharmaceuticals Pipeline

DrugIndicationPhase
RDX-002Antipsychotic-Induced Weight Gain (AIWG)Phase 1b